Risk factors and clinical presentation of hepatitis C virus infection in Nigerians with chronic liver disease

Tropical Doctor

Volumn 41, Issue 3, 2011, Pages 146-147

  Olokoba, Abdulfatai B ^a   Accama, Laraba A ^b   Gashau, Wadzani ^b   Salawu, Fatai K ^c  

^a UNIVERSITY OF ILORIN   (Nigeria)

^b UNIVERSITY OF MAIDUGURI   (Nigeria)

^c FEDERAL MEDICAL CENTER   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASCITES; BIOCHEMISTRY; BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; ECHOGRAPHY; FEMALE; HEPATITIS C; HEPATOMEGALY; HUMAN; JAUNDICE; MAJOR CLINICAL STUDY; MALE; NIGERIA; PHYSICAL EXAMINATION; QUESTIONNAIRE; RISK FACTOR; SCAR FORMATION; SPLENOMEGALY; STRUCTURED INTERVIEW; SWELLING;

ADOLESCENT; ADULT; AGED; BLOOD TRANSFUSION; CHRONIC DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; NIGERIA; RISK FACTORS; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 79960152089     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1258/td.2011.100378     Document Type: Article

References (10)

1. Tsega E. The Liver. In: Parry E, Geoffrey R, Mabey D, Gill G, eds. Principles of Medicine in Africa. 3rd edn. Cambridge: Cambridge University Press; 2004:991-1007
2. EASL. International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol, 1999;30:956-61
3. Isselbacher KJ, Wands JR. Neoplasms of the liver. In: Wilson JD, Braunwald, Isselbacher K, et al., eds. Harrison's Principle of Internal Medicine. 12th edn. New York: McGraw Hill; 1991:1350-2
4. Lesi OA, Kehinde MO, Anomneze EE. Chronic liver disease in Lagos: a clinico-pathological study. Niger Posrgrad Med J, 2004;11:91-6
5. Olokoba AB, Aderibigbe SA, Kayode OO. A community survey of practices related to risk factors for liver diseases among adults in Ilorin metropolis. Am J Sci Ind Res, 2010;1:118-21
6. Khokhar N, Niazi SA. Chronic liver disease related mortality pattern in Northern Pakistan. J Coll Physicians Surg Pak, 2003;13:495-7
7. Bastie A, Pawlotsky JM, Roudot-Thoraval F, Dhumeaux D. Infection par le virus de l’hepatite C epidemiologie. Pathol Biol(Paris), 1995;43:674-80
8. Paez Jimenez A, Mohammed MK, Eldin NS, et al., Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One, 2009;4:e7193
9. Azeez-akande O, Sarki A, Wokedi EE, Olabode A, Alabi P. Seroprevalence and risk factors of HCV in patients and blood donors in Kano, Nigeria. Afr J Cln Exper Microbiol. 2010;11:170-173
10. McCusker J, Hill EM, Mayer KH. Awareness and use of hepatitis B vaccine among homosexual male clients of a Boston community health centre. Public Health Rep, 1990;105:59-64